Progesterone and estrogen receptors as prognostic variables in breast cancer.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  1983-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 6850609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prognostic value of oestrogen receptors in breast cancer

  1985cited by this paper
• Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast

  1982cited by this paper
• Oestrogen receptors and survival in early breast cancer.

  1981cited by this paper
• Estrogen receptor: A prognostic factor in breast cancer

  1981cited by this paper
• Relationship between primary breast tumor receptor status and patient survival

  1980cited by this paper
• The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer

  1980cited by this paper
• The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

  1980cited by this paper
• Possible tests for selection of adjuvant systemic therapy in early cancer of the breast

  1980cited by this paper
• Relationship of presence of progesterone receptors to prognosis in early breast cancer.

  1980cited by this paper
• Oestrogen receptors and prognosis in early breast cancer.

  1979cited by this paper
• Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast.

  1979cited by this paper
• Prognostic value of estrogen receptors in primary breast cancer

  1979cited by this paper
• Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer

  1978cited by this paper
• Progesterone and oestrogen receptors in human breast cancer.

  1978cited by this paper
• Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

  1977cited by this paper
• Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

  1975cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper
• Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.

  1955cited by this paper

• Vitamin D Receptor Polymorphisms and their role in Invasive Breast Cancer progression.

  2025cites this paper
• Development of Gel-based Multiplex RT-PCR for Detection of ER/PR/ HER2-Positive Breast Cancer Diagnosis

  2020cites this paper
• Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype

  2020cites this paper
• Immunhistochemischer Nachweis von nukleären Rezeptoren beim sporadischen Mammakarzinom

  2019cites this paper
• Steroid hormone receptors as prognostic markers in breast cancer.

  2017cites this paper
• Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis

  2017cites this paper
• High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer

  2016cites this paper
• Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival12

  2015cites this paper
• A review on metastatic breast cancer in Iran

  2015cites this paper
• Sex Steroid Hormone Receptor Expression Affects Ovarian

  2015cites this paper
• Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.

  2015cites this paper
• Factores pronósticos del cáncer de mama. Modelo

  2015cites this paper
• Ethnic differences in breast cancer outcomes in Aotearoa New Zealand

  2015cites this paper
• Advances in the proteomic discovery of novel therapeutic targets in cancer

  2013cites this paper
• Correlation o f V ascular E ndothelial G rowth F actor C ontent With R ecurrences, S urvival, a nd F irst R elapse S ite i n Primary N ode-Positive B reast C arcinoma A fter Adjuvant T reatment

  2013cites this paper
• Der prognostische Wert von klinischen Parametern und Tumoreigenschaften für einen metastatischen Befall von axillären Non-Sentinel-Lymphknoten beim Mammakarzinom

  2013cites this paper
• MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells

  2012cites this paper
• Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

  2012cites this paper
• Rapid detection of sentinel lymph node metastases in different techniques and comparison in low-grade breast carcinomas Detección rápida de metástasis en ganglio centinela y comparación de diferentes técnicas en carcinomas de mama de bajo grado

  2012cites this paper
• The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer

  2012cites this paper
• Prädiktiver Wert und Verlaufsbeobachtung der Tumorvaskularisierung in der primär systemischen Therapie des Mammakarzinoms

  2011cites this paper
• Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.

  2011cites this paper
• Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

  2010cites this paper
• Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.

  2010cites this paper
• Clinical importance of vitamin D receptor gene polymorphism in invasive ductal carcinoma.

  2009cites this paper
• [Clinical significance of steroid hormone receptor determination in breast carcinoma tissue].

  2008cites this paper
• Aus der Universitäts-Frauenklinik mit Poliklinik Tübingen Abteilung Allgemeine Geburtshilfe und Frauenheilkunde

  2007cites this paper
• Evaluation of tumor suppressor gene p53, oncogene c-erbB-2 and matrix-metalloproteinase-9 as prognostic and predictive factors in breast carcinoma

  2007cites this paper
• Carcinoma in a Mixed Mammary Tumor in a Llama (Lama Glama)

  2007cites this paper
• Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.

  2007cites this paper
• Regular Revziew Node negative breast cancer Adjuvant chemotherapy should probably be reserved for patients at high risk of relapse

  2006cites this paper
• Nitric oxide and hormones in breast cancer: allies or enemies?

  2006cites this paper
• Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells

  2006cites this paper
• Expression of selected markers in patients treated for breast cancer – based on our own data

  2006cites this paper
• Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

  2005cites this paper
• Prognostic implication of estrogen receptor content in breast cancer

  2005influential citation
• Cancer Treatment and Research

  2005cites this paper
• Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy

  2005cites this paper
• Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand

  2005cites this paper
• Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand

  2005cites this paper
• Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.

  2005cites this paper
• Expression of female sex hormone receptors in human middle-ear cholesteatomas

  2005cites this paper
• Prognostic factors in primary breast cancer

  2005cites this paper
• Progesterone enhances cytokine-stimulated nitric oxide synthase II expression and cell death in human breast cancer cells

  2005cites this paper
• Hormonal influences on cancer progression and prognosis.

  2005cites this paper
• Seasonal variation in breast cancer detection: Correlation with tumour progesterone receptor status

  2005cites this paper
• Estradiol and progesterone receptors in breast cancer: Prognostic value after relapse

  2005cites this paper
• Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status

  2005cites this paper
• Genetic evolution of breast cancer: II. relationship with estrogen and progesterone receptor expression

  2005cites this paper
• Transferrin receptor is inversely correlated with estrogen receptor in breast cancer

  2005cites this paper
• The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survial

  2004cites this paper
• Human Small Breast Epithelial Mucin: The Promise of a New Breast Tumor Biomarker

  2004cites this paper
• Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression

  2004cites this paper
• Factores pronósticos del cáncer de mama. Modelo predictivo

  2004cites this paper
• The relationship of estrogen receptor status to DNA ploidy in breast cancer

  2004cites this paper
• The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer.

  2003cites this paper
• Leader Biological indices in the assessment of breast cancer

  2003cites this paper
• An immunohistochemical study

  2003cites this paper
• Estrogen receptors in human thyroid gland. An immunohistochemical study.

  2003cites this paper
• Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre.

  2003cites this paper
• Biomarcadores en el pronóstico y respuesta al tratamiento en cáncer mamario

  2002cites this paper
• Receptores hormonales en cáncer de mama

  2002cites this paper
• Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.

  2002cites this paper
• Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.

  2001cites this paper
• Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.

  2000cites this paper
• A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas

  2000cites this paper
• Steroid hormone receptors and long term survival in invasive ovarian cancer

  2000cites this paper
• Time-dependent relevance of steroid receptors in breast cancer.

  2000cites this paper
• Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania.

  2000cites this paper
• Expression of progesterone receptor in human keratinocytes.

  2000cites this paper
• Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

  1999cites this paper
• pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.

  1998cites this paper
• The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index

  1998cites this paper
• Expression of c‐met is a strong independent prognostic factor in breast carcinoma

  1998cites this paper
• hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines.

  1998cites this paper
• Progress in endocrine therapy for breast carcinoma

  1998cites this paper
• Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas.

  1998cites this paper
• Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCR.

  1998cites this paper
• New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry

  1997cites this paper
• Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.

  1997cites this paper
• Prognostic and predictive factors in breast cancer.

  1997cites this paper
• Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.

  1997cites this paper
• The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.

  1997cites this paper
• Prognostic and response markers in the management of breast cancer.

  1997cites this paper
• Application of neoadjuvant chemoendocrine therapy for operable breast carcinomas.

  1997cites this paper
• Changing trends in the diagnosis and treatment of early breast cancer.

  1997cites this paper
• Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.

  1996cites this paper
• Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients.

  1996cites this paper
• Oestrogen receptor: a stable phenotype in breast cancer.

  1996cites this paper
• Oestrogen and Progesterone Receptors as Prognostic Variables in Hormonally Treated Breast Cancer

  1996cites this paper
• Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.

  1996cites this paper
• Adjuvant Therapy of Node-Negative Breast Cancer

  1995cites this paper
• Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.

  1995cites this paper
• Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.

  1995cites this paper
• Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

  1995cites this paper
• Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group.

  1994cites this paper
• Prognostic factors in early breast carcinoma

  1994cites this paper
• Lymph node-negative breast cancer: the prognostic role and time dependency of age, tumor diameter and mean nuclear area.

  1994cites this paper
• Prediction of Axillary Lymph Node Metastases in a Screened Breast Cancer Population

  1994cites this paper
• AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.

  1994cites this paper